EUVIMEDOpdag EUVIMED
KohortenstudieOpen access · CC BY-NC-ND 4.0

Former long‐term use of combined hormonal contraception and glucose metabolism disorders in perimenopausal women: A prospective, population‐based cohort study

Maria-Elina Mosorin iD, Meri-Maija Ollila iD, Tanja Nordström, Jari Jokelainen, Terhi Piltonen, Juha Auvinen, Laure Morin-Papunen, Juha Tapanainen iD

Acta Obstetricia et Gynecologica Scandinavica · 2023

DOI: 10.1111/aogs.14636 ↗

At a glance

Kohortenstudie in Acta Obstetricia et Gynecologica Scandinavica, 2023. Written by Maria-Elina Mosorin and 7 co-authors. Institution: Department of Obstetrics and Gynecology, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia, University of Oulu, Oulu, Finland. Major MEDLINE topics: Diabetes Mellitus, Type 2, Glucose Metabolism Disorders, Hormonal Contraception, Prediabetic State. Cited 11 times so far (Crossref); 26 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Academy of Finland, ERDF European Regional Development Fund Grant, Helsinki University Hospital Research Funds.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Current use of combined hormonal contraceptives worsens glucose tolerance and increases the risk of type 2 diabetes mellitus at late fertile age, but the impact of their former use on the risk of glucose metabolism disorders is still controversial. Material and methods This was a prospective, longitudinal birth cohort study with long‐term follow‐up consisting of 5889 women. The cohort population has been followed at birth, and at ages of 1, 14, 31 and 46. In total, 3280 (55.7%) women were clinically examined and 2780 also underwent a 2‐h oral glucose tolerance test at age 46. Glucose metabolism indices were analyzed in former combined hormonal contraceptive users ( n = 1371) and former progestin‐only contraceptive users ( n = 52) and in women with no history of hormonal contraceptive use ( n = 253).

Results

Compared with women with no history of hormonal contraceptive use, those who formerly used combined hormonal contraceptives for over 10 years had an increased risk of prediabetes (odds ratio [OR] 3.9, 95% confidence interval [CI]: 1.6–9.2) but not of type 2 diabetes mellitus. Former progestin‐only contraceptive use was not associated with any glucose metabolism disorders. The results persisted after adjusting for socioeconomic status, smoking, alcohol consumption, parity, body mass index and use of cholesterol‐lowering medication.

Conclusions

Former long‐term use of combined hormonal contraceptives was associated with a significantly increased risk of prediabetes in perimenopausal women, which potentially indicates a need of screening for glucose metabolism disorders in these women.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 2Glucose Metabolism DisordersHormonal ContraceptionPrediabetic StateFemaleHumansInfant, NewbornMiddle AgedCohort StudiesContraceptionContraceptives, Oral, CombinedContraceptives, Oral, HormonalPerimenopauseProgestinsProspective Studies

Author keywords

OGTTcombined hormonal contraceptionglucose metabolism disordersprediabetesprogestin-only contraceptiontype 2 diabetes mellitus

Substances

Contraceptives, Oral, CombinedContraceptives, Oral, HormonalProgestins

Authors and institutions

  • Department of Obstetrics and Gynecology, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia, University of Oulu, Oulu, Finland.
  • Medical Research Center, Oulu University Hospital, University of Oulu, Wellbeing Services County of North Ostrobothnia, Oulu, Finland.
  • Research Unit of Clinical Medicine Oulu University Hospital, University of Oulu, Wellbeing Services County of North Ostrobothnia, Oulu, Finland.
  • Center for Life Course Health Research, University of Oulu, Wellbeing Services County of North Ostrobothnia, Oulu, Finland.
  • Unit of General Practice, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia, Oulu, Finland.
  • Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

ORCID profiles: Maria-Elina Mosorin, Meri-Maija Ollila, Juha Tapanainen

Funding

  • Academy of Finland
  • ERDF European Regional Development Fund Grant
  • Helsinki University Hospital Research Funds
  • Oulu University Hospital Grant
  • Oulu University Hospital Research Funds
  • Oulu University Medical Research Center
  • Sigrid Juselius foundation
  • University of Oulu Grant

Cite

APA

Mosorin, M. E., Ollila, M. M., Nordström, T., Jokelainen, J., Piltonen, T., Auvinen, J., Morin-Papunen, L., & Tapanainen, J. (2023). Former long‐term use of combined hormonal contraception and glucose metabolism disorders in perimenopausal women: A prospective, population‐based cohort study. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14636

Vancouver

Mosorin ME, Ollila MM, Nordström T, Jokelainen J, Piltonen T, Auvinen J, et al. Former long‐term use of combined hormonal contraception and glucose metabolism disorders in perimenopausal women: A prospective, population‐based cohort study. Acta Obstetricia et Gynecologica Scandinavica. 2023. doi:10.1111/aogs.14636

BibTeX
@article{Mosorin2023,
  author = {Mosorin, Maria-Elina and Ollila, Meri-Maija and Nordström, Tanja and Jokelainen, Jari and Piltonen, Terhi and Auvinen, Juha and Morin-Papunen, Laure and Tapanainen, Juha},
  title = {Former long‐term use of combined hormonal contraception and glucose metabolism disorders in perimenopausal women: A prospective, population‐based cohort study},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2023},
  doi = {10.1111/aogs.14636}
}
Start for free →